Last edition
News about "clinical trial application "
Arrowhead and Novartis Sign Global License and Collaboration Deal
Novartis secures exclusive global rights to Arrowhead’s ARO-SNCA therapy for Parkinson’s and related disorders, with Arrowhead receiving USD 200 million upfront.
Clinical Trial Application | 05/09/2025 | By Dineshwori
CStone Submits Clinical Trial Application in Australia for CS2009
CS2009 features an innovative molecular design that targets PD-1, VEGFA, and CTLA-4 simultaneously, maintaining balanced affinity for PD-1 and CTLA-4.
Clinical Trial Application | 23/12/2024 | By Aishwarya | 125
Epigenic Therapeutics to Initiate Clinical Development of EPI-003
This first-in-human study will assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of EPI-003 in Nucleos(t)ide Analogue-Treated, Chronic Hepatitis B Patients.
Clinical Trial Application | 20/11/2024 | By Aishwarya | 281
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy